
Opinion|Videos|July 24, 2024
Ensuring PNH Treatment Access and Adherence to Therapies
Barriers to care and treatment adherence for patients diagnosed with PNH is discussed.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What strategies can effectively ensure seamless access to therapies (eg, partnering with specialized pharmacies for dispensing)?
- When considering treatment options, how do factors related to supporting and enhancing adherence influence your choice of therapy? Could you discuss the opportunities and approaches you leverage to promote optimal treatment adherence in this patient population?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success
2
Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups
3
High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial
4
AHA Proposes Staging System for Pediatric Cardiogenic Shock
5





